
The Case for COVID-19 Antibody Therapies
Jul 10, 2020 & call for greater investment in new genetically engineered treatments to combat the coronavirus.
Michel D. Kazatchkine, a senior fellow at the Graduate Institute of International and Development Studies in Geneva and a member of the Global Commission on Drug Policy, was Executive Director of the Global Fund to Fight AIDS, Tuberculosis, and Malaria from 2007 to 2012.
Jul 10, 2020 & call for greater investment in new genetically engineered treatments to combat the coronavirus.